-+ 0.00%
-+ 0.00%
-+ 0.00%

FENNEC PHARMACEUTICALS ANNOUNCES ORAL PRESENTATION OF DETAILED RESULTS FROM INVESTIGATOR-INITIATED PHASE 2 STS-J01 CLINICAL STUDY OF PEDMARK® IN JAPAN AT SIOP 2026

Reuters·09/17/2026 11:30:00

Please log in to view news